Clinical characteristics of COVID-19 rebound after nirmatrelvir-ritonavir or molnupiravir therapy: A prospective cohort study

The clinical characteristics of the rebound phenomenon after antiviral therapy in patients with Coronavirus disease-2019 (COVID-19) are largely unknown. There are few data comparing the rebound phenomenon after molnupiravir therapy to that after nirmatrelvir-ritonavir therapy. We investigated the in...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jaijun, Bae, Seongman, Jung, Jiwon, Kim, Min Jae, Chong, Yong Pil, Lee, Sang-Oh, Choi, Sang-Ho, Kim, Yang Soo, Chang, Euijin, Kim, Sung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545339/
https://www.ncbi.nlm.nih.gov/pubmed/37773854
http://dx.doi.org/10.1097/MD.0000000000035094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545339/
https://www.ncbi.nlm.nih.gov/pubmed/37773854
http://dx.doi.org/10.1097/MD.0000000000035094

Ejemplares similares